🇺🇸 FDA

Company profile · Sponsor

Tanabe

Tanabe Pharma

EC2BE83 · NMPA pharma CN
Pipeline
4
Drugs
0
Patents
0

Quick answer

Tanabe (EC2BE83) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EC2BE83
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (4)

Search pipeline →

  1. MT-1186

    Tanabe

    ALS

    phase 3 small molecule terminated

    1 trial

  2. MT-5547

    Tanabe

    Osteoarthritis, Knee / Osteoarthritis, Hip

    phase 3 small molecule completed

    1 trial

  3. MCI-186

    Tanabe

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  4. MT-1186

    Tanabe

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Tanabe?

Tanabe (EC2BE83) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Tanabe sponsor?

We track 4 ClinicalTrials.gov-linked programs for Tanabe, including MT-1186 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Tanabe company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.